$NVAX Headlines Herbalife shares wobble on earnings

New Post Public Reply Private Reply Replies (0) Message Board

May 30, 2014 at 9:55 AM

$NVAX Headlines

Herbalife shares wobble on earnings beat, cut dividend 6:16 p.m. April 28, 2014 - Wallace Witkowski
Novavax Inc. up 16% in premarket 7:52 a.m. Oct. 25, 2012 - Steve Gelsi
Novavax gains 11% on flu vaccine update 12:29 p.m. July 25, 2012 - Val Brickates Kennedy
Tuesday’s biggest gainers and decliners 7:42 p.m. March 1, 2011 - Kate Gibson
Novavax grabs drug-stock spotlight 1:49 p.m. March 1, 2011 - Val Brickates Kennedy
Novavax shares rally on government contract 11:03 a.m. March 1, 2011 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 4:38 p.m. July 27, 2010 - MarketWatch
Baxter, Affymetrix lead drug stocks lower 2:05 p.m. April 22, 2010 - Val Brickates Kennedy
Wednesday's biggest gaining and declining stocks 4:56 p.m. March 24, 2010 - MarketWatch
Poniard, Genzyme lead drug stocks south 11:10 a.m. March 24, 2010 - Val Brickates Kennedy
Drug stocks turn higher; Shire, XenoPort gain 1:59 p.m. Feb. 19, 2010 - Val Brickates Kennedy
Monday's biggest gaining and declining stocks 6:16 p.m. Feb. 8, 2010 - MarketWatch
Drug stocks turn higher; Cell Therapeutics tumbles 2:14 p.m. Feb. 8, 2010 - Val Brickates Kennedy
Novavax shares down 9% 10:37 a.m. Feb. 8, 2010 - Nick Godt
Novavax, Rovi end flu-vaccine-development plan 3:27 a.m. Feb. 8, 2010 - Robert Daniel
Novavax raises $21 million in stock offering 10:10 a.m. Dec. 9, 2009 - Val Brickates Kennedy
Dyax, Santarus, CytRx soar; Hemispherx craters 12:38 p.m. Dec. 2, 2009 - Val Brickates Kennedy
Drug stocks split; Theravance slides on setback 2:22 p.m. Nov. 30, 2009 - Val Brickates Kennedy
Novavax sees Phase III vaccine testing in 2010 10:32 a.m. Nov. 30, 2009 - Val Brickates Kennedy
Inovio, Merck gain; Novavax falls 5:26 p.m. Nov. 20, 2009 - Val Brickates Kennedy

Five Star Biotech Stock Watch: Novavax 2:15 p.m. May 28, 2014 - benzinga.com
Novavax (NVAX) In A Perilous Reversal 9:54 a.m. May 28, 2014 - TheStreet.com
In Case Of MERS Emergency - Break Glass, Buy Novavax 2:01 p.m. May 20, 2014 - Seeking Alpha
Interesting NVAX Put And Call Options For January 2015 10:51 a.m. May 20, 2014 - TheStreet.com
Novavax: A Unique Opportunity 3:06 p.m. May 15, 2014 - Seeking Alpha
One Year Follow-Up From RSV F-Protein Vaccine Candidate Phase 1 Elderly Trial Demonstrates Sustained Levels of Immune Response 8:01 a.m. May 12, 2014 - benzinga.com
10-Q: NOVAVAX INC 5:24 p.m. May 8, 2014 - Edgar Online - (EDG = 10Q, 10K)
Novavax's (NVAX) CEO Stanley Erck on Q1 2014 Results - Earnings Call Transcript 10:00 p.m. May 7, 2014 - Seeking Alpha
Novavax's VP of R&D Says Production of MERS Vaccine is Analagous to Situation Described in NEJM Paper on H7n9 8:43 a.m. May 4, 2014 - benzinga.com
NVAX bounces 3:20 p.m. April 29, 2014 - Seeking Alpha
Novavax (NVAX) Shares Cross Above 200 DMA 11:41 a.m. April 29, 2014 - TheStreet.com
Why Novavax (NVAX) Stock Is Higher Today 9:25 a.m. April 29, 2014 - TheStreet.com
Novavax Respiratory Ailment Vaccine for Women Shows Positive Results 6:01 p.m. April 28, 2014 - The Wall Street Journal Interactive Edition
Novavax Announces Positive Top-Line Data from Dose-Confirmatory Phase 2 Clinical Trial of RSV Vaccine, 3:14 p.m. April 28, 2014 - benzinga.com
'Mad Money' Lightning Round: I Like M&T Bank 6:00 a.m. April 24, 2014 - TheStreet.com
Cramer's Lightning Round - Don't Chase Under Armour Into The Quarter (4/23/14) 5:18 a.m. April 24, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: The Market's New Reality 8:20 p.m. April 23, 2014 - TheStreet.com
First Week Of June 21st Options Trading For Novavax (NVAX) 1:10 p.m. April 22, 2014 - TheStreet.com
Stock To Watch: Novavax (NVAX) In Perilous Reversal 9:52 a.m. April 17, 2014 - TheStreet.com
Novavax: Promising Pipeline And Stable Revenue Add To Upside 8:43 a.m. April 8, 2014 - Seeking Alpha

Pre-Market Pulse on Top Gainers -- Research on Inovio Pharma, Novavax, FreeSeas, and ImmunoCellular Therapeutics 11:05 a.m. May 20, 2014 - PR Newswire - PRF
Clinical Trial Updates, Leadership Appointments, and Earnings Results - Analyst Notes on Tesaro, Novavax, Vanda, Insmed and Durata 8:30 a.m. May 15, 2014 - PR Newswire - PRF
One Year Follow-Up From RSV F-Protein Vaccine Candidate Phase 1 Elderly Trial Demonstrates Sustained Levels of Immune Response 9:12 a.m. May 12, 2014 - Thomson Reuters ONE
Novavax Reports First-Quarter 2014 Financial Results 11:17 p.m. May 7, 2014 - Thomson Reuters ONE
Novavax Appoints Sven Andreasson as Senior Vice President, Corporate Development 4:33 p.m. May 6, 2014 - Thomson Reuters ONE
Novavax Appoints Sven Andreasson as Senior Vice President, Corporate Development 4:31 p.m. May 6, 2014 - GlobeNewswire
Positive Data, Financial Results, and Drug Development Programs - Analyst Notes on Novavax, Ironwood, XOMA, Luminex and Amicus 8:00 a.m. May 2, 2014 - PR Newswire - PRF
Novavax to Report First Quarter Financial Results on May 7, 2014 12:14 p.m. May 1, 2014 - Thomson Reuters ONE
Novavax to Report First Quarter Financial Results on May 7, 2014 11:39 a.m. May 1, 2014 - GlobeNewswire
New Experimental Vaccine Produces Immune Response Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) 8:02 a.m. April 30, 2014 - Thomson Reuters ONE
New Experimental Vaccine Produces Immune Response Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) 8:01 a.m. April 30, 2014 - GlobeNewswire
Morning Review on Top Gainers -- Research on Banco Santander Brasil, Novavax, Cadence Design Systems, and Amicus Therapeutics 8:00 a.m. April 30, 2014 - PR Newswire - PRF
Novavax Announces Positive Top-Line Data from Dose-Confirmatory Phase 2 Clinical Trial of its RSV Vaccine Candidate in Women of Childbearing Age 4:24 p.m. April 28, 2014 - Thomson Reuters ONE
Amarin Corp. and Kowa Pharmaceuticals to Begin Joint Vascepa Promotion in May 12:25 p.m. April 11, 2014 - ACCESSWIRE
Novavax Appoints Dr. Cindy Oliver as Senior Vice President, Process Development Operations 12:49 p.m. April 7, 2014 - Thomson Reuters ONE
Novavax Appoints Dr. Cindy Oliver as Senior Vice President, Process Development Operations 12:34 p.m. April 7, 2014 - GlobeNewswire
Novavax to Present at the 13th Annual Needham Healthcare Conference 4:12 p.m. April 2, 2014 - Thomson Reuters ONE
Novavax to Present at the 13th Annual Needham Healthcare Conference 4:10 p.m. April 2, 2014 - GlobeNewswire
Top Gainers at a Glance -- Research on Lions Gate Entertainment, Novavax, Glu Mobile, and Vipshop Holdings 9:17 a.m. April 1, 2014 - PR Newswire - PRF
Microvision Raises $13.9 Million with New Stock Offering 9:43 a.m. March 27, 2014 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trading Platforms Poised for Billions by 2031

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

The Real Cost of Cabinet Decisions: Refinish or Replace?

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Kal Plastics Showcases at Design-2-Part Expo

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Vatrer Power: Lithium Batteries Revolutionize Golf Carts

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Aetna's 2027 Medicare Plans: Comprehensive Outlook

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Venice's Climate Challenge: Rising Seas, Sinking Lands

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Honeywell's Supply Line Snags Bait Class Action Risk

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Govee Stirs Halloween Chills with New Sarah Gellar Ad

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...